Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation | |
---|---|---|
drug623 | COVID-19 convalescent plasma Wiki | 1.00 |
drug385 | BNT162b2 Wiki | 0.50 |
drug2490 | Placebo Wiki | 0.13 |
Name (Synonyms) | Correlation |
---|
Navigate: Correlations HPO
There is one clinical trial.
The purpose of this study is to identify early signals of efficacy or harm associated with convalescent plasma therapy in a population of Veteran inpatients with coronavirus disease 2019 (COVID-19).
Description: Death at any time after admission recorded in the electronic health record. Specific estimates of risk of death will be produced for 7 days, 14 days, 21 days and 28 days, and total deaths.
Measure: All-cause mortality Time: up to 28 daysDescription: Number of days from index date to first intubation in non-mechanically ventilated patients
Measure: Time to first intubation Time: 28 daysDescription: Number of days from index date to hospital discharge
Measure: Time to hospital discharge Time: 28 daysDescription: Number of days from index date to death from any cause
Measure: Time to all-cause mortality Time: 28 daysDescription: Long-term outcomes will include death at one year following the index date.
Measure: All-cause mortality Time: 1 yearAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports